These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8845484)

  • 1. Saturation reversal of the multidrug pump using many reversers in low-dose combinations.
    Lyubimov E; Lan LB; Pashinsky I; Ayesh S; Stein WD
    Anticancer Drugs; 1995 Dec; 6(6):727-35. PubMed ID: 8845484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saturable function of P-glycoprotein as a drug-efflux pump in multidrug-resistant tumour cells.
    Miyamoto KI; Koga-Takeda K; Koga K; Ohshima T; Nomura M
    J Pharm Pharmacol; 1996 May; 48(5):522-5. PubMed ID: 8799879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutually co-operative interactions between modulators of P-glycoprotein.
    Shao YM; Ayesh S; Stein WD
    Biochim Biophys Acta; 1997 Feb; 1360(1):30-8. PubMed ID: 9061037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug accumulation in the presence of the multidrug resistance pump: dissociation between verapamil accumulation and the action of P-glycoprotein.
    Ayesh S; Litman T; Stein WD
    Recept Channels; 1997; 5(3-4):175-83. PubMed ID: 9606721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo.
    Wang L; Kitaichi K; Hui CS; Takagi K; Takagi K; Sakai M; Yokogawa K; Miyamoto KI; Hasegawa T
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):587-93. PubMed ID: 10901387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.
    Dale IL; Tuffley W; Callaghan R; Holmes JA; Martin K; Luscombe M; Mistry P; Ryder H; Stewart AJ; Charlton P; Twentyman PR; Bevan P
    Br J Cancer; 1998 Oct; 78(7):885-92. PubMed ID: 9764579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein.
    Ayesh S; Shao YM; Stein WD
    Biochim Biophys Acta; 1996 May; 1316(1):8-18. PubMed ID: 8634345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of P-glycoprotein is greatly reduced by the presence of plasma but can be monitored by an ex vivo clinical assay.
    Ayesh S; Lyubimov E; Algour N; Stein WD
    Anticancer Drugs; 1996 Aug; 7(6):678-86. PubMed ID: 8913437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Calphostin C (PKC inhibitor) on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possibly via P-glycoprotein.
    Gupta S; Patel K; Singh H; Gollapudi S
    Cancer Lett; 1994 Jan; 76(2-3):139-45. PubMed ID: 7511983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide.
    Nakashima E; Matsushita R; Negishi H; Nomura M; Harada S; Yamamoto H; Miyamoto K; Ichimura F
    J Pharm Sci; 1995 Oct; 84(10):1205-9. PubMed ID: 8801335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistance transporter P-glycoprotein has distinct but interacting binding sites for cytotoxic drugs and reversing agents.
    Pascaud C; Garrigos M; Orlowski S
    Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):351-8. PubMed ID: 9657975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of new non-cross-resistant antitumor compounds of the benzoperimidine family in multidrug resistant cells.
    Tkaczyk-Gobis K; Tarasiuk J; Seksek O; Stefanska B; Borowski E; Garnier-Suillerot A
    Eur J Pharmacol; 2001 Feb; 413(2-3):131-41. PubMed ID: 11226386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic parameters for reversal of the multidrug pump as measured for drug accumulation and cell killing.
    Lan LB; Ayesh S; Lyubimov E; Pashinsky I; Stein WD
    Cancer Chemother Pharmacol; 1996; 38(2):181-90. PubMed ID: 8616910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal effects of antifungal drugs on multidrug resistance in MDR1-overexpressing HeLa cells.
    Iida N; Takara K; Ohmoto N; Nakamura T; Kimura T; Wada A; Hirai M; Sakaeda T; Okumura K
    Biol Pharm Bull; 2001 Sep; 24(9):1032-6. PubMed ID: 11558564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel inhibitors for multidrug resistance: 1,3,5-triazacycloheptanes.
    Sawanishi H; Wakusawa S; Murakami R; Muramatsu H; Suzuki H; Takashima A; Aizawa T; Miyamoto K
    J Med Chem; 1995 Dec; 38(26):5066-70. PubMed ID: 8544183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP).
    Lehne G; Mørkrid L; den Boer M; Rugstad HE
    Int J Clin Pharmacol Ther; 2000 Apr; 38(4):187-95. PubMed ID: 10783828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of daunomycin and vinblastine resistance in multidrug-resistant P388 leukemia in vitro through enhanced cytotoxicity by triterpenoids.
    Hasegawa H; Sung JH; Matsumiya S; Uchiyama M; Inouye Y; Kasai R; Yamasaki K
    Planta Med; 1995 Oct; 61(5):409-13. PubMed ID: 7480200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein.
    Quesada AR; García Grávalos MD; Fernández Puentes JL
    Br J Cancer; 1996 Sep; 74(5):677-82. PubMed ID: 8795567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular uptake and antiproliferative effects of therapeutic concentrations of idarubicin or daunorubicin and their alcohol metabolites, with or without cyclosporin A, in MDR1+ human leukemic cells.
    Chiodini B; Bassan R; Barbui T
    Leuk Lymphoma; 1999 May; 33(5-6):485-97. PubMed ID: 10342576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes.
    Vergote J; Moretti JL; de Vries EG; Garnier-Suillerot A
    Eur J Biochem; 1998 Feb; 252(1):140-6. PubMed ID: 9523723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.